A case of parathyroid tumour associated with fibrocystic disease With a pathological account

1932 ◽  
Vol 19 (76) ◽  
pp. 606-618 ◽  
Author(s):  
G. Gordon-Taylor ◽  
Philip Wiles ◽  
S. L. Baker
2016 ◽  
pp. 72-74 ◽  
Author(s):  
M. Makarenko ◽  
◽  
D. Govsieiev ◽  
O. Gromova ◽  
L. Martynova ◽  
...  

The objective: to study the incidence of gynecological diseases, clinical and hormonal parameters of the menstrual cycle in patients with benign hyper-plastic processes of breasts. Patients and methods. 65 women with various forms of mastitis were investigated. The following investigations were conducted: mammologistic and gynecological investigation, mommologistic X-ray investigation, ultrasound of breasts and of the pelvic organs, endometrial aspiration biopsy that was followed by cytology; when it was necessary the diagnostic laparoscopy, colposcopy, hysteroscope with curettage and morphological investigation of the endometrium, hormone research and rectal temperature measurements were conducted. Results. The frequency of the benign breast diseases was set: fibrocystic disease of breast – 32 women (49.2±6.20%), fibrous of breast – 16 women (24.6±5.34%), nodular of breasts – 8 women (12.3±4.07%), fibroadenoma – 6 women (9.2±3.59%), nodular disease of breasts on the background of fibroid changes – 3 women (4.6±2.60%). All in all, 96.9±2.14% of the patients had any gynecological diseases. Thus, the average age of the ‘debut’ of mastitis was 31.4±1.09 years; the hyper-plastic processes in the uterus was 35.2±1.17 years. Anovulation was detected in 17 (47.2±8.3%) patients, the lack of the luteal phase (NLF) was detected in 11 (30.6±7.6) patients. Conclusions. Identified hormonal changes are typical for patients with the hyper-plastic processes of the reproductive organs with different localization (breasts, uterus, ovaries). Due to the commonality of the hormone changes in most cases mastitis is combined with the various gynecological diseases (96.9±2.14%). Key words: gynecological pathology, hormonal changes, breast, factors of risk.


1971 ◽  
Vol 79 (6) ◽  
pp. 1011-1014 ◽  
Author(s):  
Marion J. Balsam ◽  
Philip G. Holtzapple ◽  
Robert Kaye ◽  
Edward M. Sewell

1961 ◽  
Vol 6 (5) ◽  
pp. 447-453 ◽  
Author(s):  
Albert I. Mendeloff
Keyword(s):  

1986 ◽  
Vol 464 (1 Endocrinology) ◽  
pp. 620-621
Author(s):  
L. FALSETTI ◽  
P. SCAGLIOLA ◽  
R. TURLA ◽  
U. OMODEI ◽  
D. DORDONI

2018 ◽  
Vol 8 (2) ◽  
pp. 54-57
Author(s):  
Md Monoarul Islam Talukdar ◽  
Nadim Ahmed ◽  
Md Abul Kalam Azad ◽  
Mohammad Emrul Hasan Khan ◽  
Fayem Chowdhury ◽  
...  

Background: Benign disorder of breast in female usually seen in reproductive period of life, is thought to be largely hormone induced and there is a dramatic fall in the incidence after menopause due to cessation of ovarian stimulation.Objectives: To find out the relationship between different types of benign breast disease and hormones acting on breast mainly oestrogen, testesteron and prolactin.Methodology: This is a prospective observational study conducted in the department of surgery, Shaheed Suhrawardy Medical College Hospital. Total 150 female patients of reproductive age were included in the study. Serum levels of oestrogen, testosterone and prolactin were done in all patients. Other relevant radiological and cytological investigations were done accordingly where indicated.Results: Mean age of the study subjects were 28 ±8.46 years. Among the study subjects 64 (42.7%) patients used hormonal contraception, on the other hand 86 patients (57.3%) did not used hormonal contraceptive. 68 (45.3%) patients were non parous, 29( 19.3%) were primi parous and 53 ( 35.3%) were multiparous. 87 (58%) had positive history of breast feeding, 63 (42%) patients did not breast fed their babies. Fibrocystic disease was most common diagnosis among study group followed by fibroadenoma. 96 (64%) patients had fibrocystic disease followed by 38 (25.3%) had fibroadenoma. Mean oestrogen, testosterone and prolactin level was 71.16± 57.63 pg/ml, 0.59 ± 0.42 nmol/L and 22.61 ± 16.65 ng/ml respectively.Conclusion: With this small sample size it is difficult to conclude regarding relation between oestrogen, testosterone, prolactin and benign breast disease. But this study can be used as a base line document regarding benign breast disease, hormone profile, type, distribution and frequency of benign breast disease.J Shaheed Suhrawardy Med Coll, December 2016, Vol.8(2); 54-57


2016 ◽  
Vol 23 (3) ◽  
Author(s):  
Gordiy Olegovych Rybchynsky

This publication describes the main reasons and some aspects of breast defective scar appearance and explains the comprehensive impact of risk factors leading to their appearance. Some examples of minimum invasive treatment of defective scars using the author’s own method of treatment as well as the way of patients’ management after surgical treatment of defective scars or after breast sector resection aimed at prevention of defective scars recurrence are provided. The importance and topicality of esthetic factor in patients with fibrocystic disease of breast with chronic inflammatory component including untreated one are highlighted.


Radiology ◽  
1989 ◽  
Vol 171 (2) ◽  
pp. 583-584
Author(s):  
E S Gerson
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document